New ECCO dietary therapy guidelines for IBD clarify the role of enteral nutrition, Mediterranean diet, supplements, and RD ...

Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate ...

ON THIS PAGESymptomsComplicationsWhy Fulminant Colitis OccursWhat to Do During a Severe UC FlareAfter a Fulminant UC EpisodeFor some people with ulcerative colitis (UC), the symptoms are mild. But for ...

This time-restricted eating pattern has shown promise in some preliminary research, but is it recommended for use in UC? Find out what experts and research say.

New long-term data from Eli Lilly and Company showed Omvoh (mirikizumab-mrkz) delivered durable efficacy through three years in adults with moderately to severely active Crohn's disease.1 These data ...

A forceps left inside a Kerala woman during a 2021 hysterectomy was found years later, triggering a probe, legal action and renewed focus on surgical safety.

Eli Lilly operates in the healthcare sector as a global pharmaceutical manufacturer with commercial medicines and a broad research portfolio across immunology, oncology, and metabolic health. Eli ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

Thirteen years ago, Terrell Cleare was diagnosed with colorectal cancer. Today, the 55-year-old is cancer free, but says she ...

Colorectal cancer, which includes cancers of the colon and rectum, has become the leading cause of cancer deaths in people younger than 50. This is a worrying change because this disease has ...